More Atomo Diagnostics Ltd. news
Atomo Diagnostics Ltd.ASX: AT1

Atomo & Access Bio sign deal for rapid antigen test

Sep 29, 2020 at 12:51 AM EDT · Issued by Atomo Diagnostics Ltd.

Filed with ASX · Sep 29, 2020 at 12:51 AM EDT

On 6ix: 6ix.com/news/atomo-and-access-bio-sign-deal-for-rapid-antigen-test

Atomo Diagnostics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Atomo Diagnostics Ltd. on 6ix

Story so far

  • Atomo & Access Bio enter North American COVID-19 partnershipJul 28, 2020

Earlier from Atomo Diagnostics

  • DIVOC Labs to sell Atomos COVID-19 test in IndiaSep 23, 2020
  • FY20 Results PresentationAug 30, 2020
  • Atomo receives TGA approval for COVID19 antibody testAug 10, 2020
  • Atomo & Access Bio enter North American COVID-19 partnershipJul 28, 2020
  • Quarterly Activity Report & Appendix 4C - 30 June 2020Jul 22, 2020

Later from Atomo Diagnostics

  • Atomo receives TGA approval for COVID19 antigen testOct 27, 2020
  • Quarterly Activity Report & Appendix 4C - 30 September 2020Oct 28, 2020
  • Managing Directors AGM PresentationNov 3, 2020
  • Atomo receives TGA approval for AtomoRapid HIV (1&2) testNov 9, 2020
  • Atomo provides update on its HIV Rapid Test businessDec 6, 2020
All Atomo Diagnostics news releases↗

Follow Atomo Diagnostics into a list and get an email when it puts out news.

Follow Atomo Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer